LGALS3 and chronic kidney disease: In a cross-sectional study including 90 patients, Gal-3 plasma level was significantly higher in macroalbuminuria (p ≤ 0.05) and for patients with poor kidney function (Stage IV–V CKD), with a prediction performance of 0.776 (CI95%[0.677, 0.875]; p ≤ 0.0001) [90].